Hoda A. El‐Bahrawy

898 total citations
28 papers, 720 citations indexed

About

Hoda A. El‐Bahrawy is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Hoda A. El‐Bahrawy has authored 28 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in Hoda A. El‐Bahrawy's work include Immunotherapy and Immune Responses (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Hoda A. El‐Bahrawy is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Hoda A. El‐Bahrawy collaborates with scholars based in Egypt, France and United States. Hoda A. El‐Bahrawy's co-authors include Nahla E. El‐Ashmawy, Naglaa F. Khedr, Eman G. Khedr, Hany Aly, Heba Elmahdy, Ashraf M. Emara, Eman M. Khedr, Eslam E. Abd El-Fattah, Mohamed L. Salem and Sahar K. Hegazy and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Biomedicine & Pharmacotherapy.

In The Last Decade

Hoda A. El‐Bahrawy

28 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hoda A. El‐Bahrawy Egypt 16 202 140 122 114 101 28 720
Berna Demircan Türkiye 15 241 1.2× 68 0.5× 60 0.5× 70 0.6× 86 0.9× 25 874
Bogusław Czerny Poland 16 328 1.6× 77 0.6× 99 0.8× 79 0.7× 93 0.9× 110 1.1k
Uğur Fırat Türkiye 16 175 0.9× 44 0.3× 96 0.8× 165 1.4× 79 0.8× 52 844
Tung‐Wei Hung Taiwan 18 308 1.5× 52 0.4× 53 0.4× 75 0.7× 103 1.0× 50 804
Dana Hoffmann United States 14 302 1.5× 43 0.3× 96 0.8× 87 0.8× 64 0.6× 20 918
Hong Yu China 20 326 1.6× 113 0.8× 49 0.4× 235 2.1× 97 1.0× 67 1.1k
Adnan Somay Türkiye 18 244 1.2× 54 0.4× 159 1.3× 227 2.0× 110 1.1× 64 1.3k
Hossam M.M. Arafa Egypt 19 257 1.3× 30 0.2× 99 0.8× 77 0.7× 94 0.9× 28 910
Aziz Karaoğlu Türkiye 11 174 0.9× 94 0.7× 69 0.6× 79 0.7× 105 1.0× 47 966

Countries citing papers authored by Hoda A. El‐Bahrawy

Since Specialization
Citations

This map shows the geographic impact of Hoda A. El‐Bahrawy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoda A. El‐Bahrawy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoda A. El‐Bahrawy more than expected).

Fields of papers citing papers by Hoda A. El‐Bahrawy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hoda A. El‐Bahrawy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoda A. El‐Bahrawy. The network helps show where Hoda A. El‐Bahrawy may publish in the future.

Co-authorship network of co-authors of Hoda A. El‐Bahrawy

This figure shows the co-authorship network connecting the top 25 collaborators of Hoda A. El‐Bahrawy. A scholar is included among the top collaborators of Hoda A. El‐Bahrawy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hoda A. El‐Bahrawy. Hoda A. El‐Bahrawy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Ashmawy, Nahla E., et al.. (2021). Amelioration of lithiatic injury to renal tissue by candesartan and sodium thiosulfate in a rat model of nephrolithiasis. PLoS ONE. 16(5). e0251408–e0251408. 3 indexed citations
2.
El‐Ashmawy, Nahla E., et al.. (2020). Modulatory Effect of Silymarin on Apoptosis in Testosterone -Induced Benign Prostatic Hyperplasia in Rats. Pathology & Oncology Research. 26(3). 1947–1956. 11 indexed citations
3.
El‐Ashmawy, Nahla E., et al.. (2018). Roflumilast, type 4 phosphodiesterase inhibitor, attenuates inflammation in rats with ulcerative colitis via down-regulation of iNOS and elevation of cAMP. International Immunopharmacology. 56. 36–42. 21 indexed citations
4.
El‐Ashmawy, Nahla E., et al.. (2018). Upregulation of PPAR-γ mediates the renoprotective effect of omega-3 PUFA and ferulic acid in gentamicin-intoxicated rats. Biomedicine & Pharmacotherapy. 99. 504–510. 39 indexed citations
5.
El‐Ashmawy, Nahla E., et al.. (2018). Suppression of inducible nitric oxide synthase and tumor necrosis factor-alpha level by lycopene is comparable to methylprednisolone in acute pancreatitis. Digestive and Liver Disease. 50(6). 601–607. 22 indexed citations
6.
El‐Ashmawy, Nahla E., et al.. (2018). Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study. Clinical and Experimental Medicine. 18(4). 535–546. 4 indexed citations
7.
El‐Ashmawy, Nahla E., et al.. (2018). Anti-inflammatory and Antioxidant Effects of Captopril Compared to Methylprednisolone in l-Arginine-Induced Acute Pancreatitis. Digestive Diseases and Sciences. 63(6). 1497–1505. 30 indexed citations
8.
El‐Ashmawy, Nahla E., et al.. (2018). Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study. Clinical & Translational Oncology. 21(5). 636–645. 10 indexed citations
9.
El‐Ashmawy, Nahla E., et al.. (2017). Downregulation of iNOS and elevation of cAMP mediate the anti-inflammatory effect of glabridin in rats with ulcerative colitis. Inflammopharmacology. 26(2). 551–559. 39 indexed citations
10.
El‐Ashmawy, Nahla E., et al.. (2017). Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms. European Journal of Nutrition. 57(3). 981–989. 33 indexed citations
11.
El‐Ashmawy, Nahla E., Eman M. Khedr, Hoda A. El‐Bahrawy, & Eslam E. Abd El-Fattah. (2016). Sorafenib effect on liver neoplastic changes in rats: more than a kinase inhibitor. Clinical and Experimental Medicine. 17(2). 185–191. 26 indexed citations
12.
El‐Ashmawy, Nahla E., et al.. (2016). Nebivolol prevents indomethacin-induced gastric ulcer in rats. Journal of Immunotoxicology. 13(4). 580–589. 56 indexed citations
13.
El‐Ashmawy, Nahla E., et al.. (2016). Gastroprotective effect of garlic in indomethacin induced gastric ulcer in rats. Nutrition. 32(7-8). 849–854. 76 indexed citations
14.
El‐Ashmawy, Nahla E., Eman M. Khedr, Hoda A. El‐Bahrawy, & Eslam E. Abd El-Fattah. (2016). Effect of Pomegranate Hull Extract on Liver Neoplastic Changes in Rats: More than an Antioxidant. Nutrition and Cancer. 68(6). 1044–1051. 16 indexed citations
15.
El‐Ashmawy, Nahla E., et al.. (2015). In vitro and in vivo studies of the immunomodulatory effect of Echinacea purpurea on dendritic cells. Journal of Genetic Engineering and Biotechnology. 13(2). 185–192. 19 indexed citations
16.
El‐Ashmawy, Nahla E., et al.. (2015). Antifibrotic effect of AT‐1 blocker and statin in rats with hepatic fibrosis. Clinical and Experimental Pharmacology and Physiology. 42(9). 979–987. 13 indexed citations
17.
El‐Bahrawy, Hoda A., et al.. (2014). Effect of Diet Intake Imbalance in Hepatocellular Carcinoma Progression. International Journal of Biology. 6(2). 1 indexed citations
18.
El‐Ashmawy, Nahla E., et al.. (2014). Biochemical/metabolic changes associated with hepatocellular carcinoma development in mice. Tumor Biology. 35(6). 5459–5466. 19 indexed citations
19.
Elmahdy, Heba, et al.. (2010). Human Recombinant Erythropoietin in Asphyxia Neonatorum: Pilot Trial. PEDIATRICS. 125(5). e1135–e1142. 154 indexed citations
20.
Emara, Ashraf M. & Hoda A. El‐Bahrawy. (2008). Green Tea Attenuates Benzene-Induced Oxidative Stress in Pump Workers. Journal of Immunotoxicology. 5(1). 69–80. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026